MARKET

EOLS

EOLS

Evolus
NASDAQ
6.36
-0.03
-0.47%
After Hours: 6.31 -0.05 -0.79% 18:19 05/08 EDT
OPEN
6.33
PREV CLOSE
6.39
HIGH
6.58
LOW
6.32
VOLUME
844.93K
TURNOVER
--
52 WEEK HIGH
12.24
52 WEEK LOW
3.860
MARKET CAP
418.84M
P/E (TTM)
-9.4869
1D
5D
1M
3M
1Y
5Y
1D
Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps
TipRanks · 3d ago
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)
TipRanks · 4d ago
BTIG Sticks to Their Buy Rating for Evolus (EOLS)
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)
TipRanks · 4d ago
Evolus Maintains Buy Rating as Scalable Growth Story Solidifies; $13 Price Target Reaffirmed
TipRanks · 4d ago
Evolus reiterates 2026 net revenue of $327M-$337M while targeting a low to mid-single-digit adjusted EBITDA margin
Seeking Alpha · 4d ago
Analysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Evolus (EOLS)
TipRanks · 4d ago
Evolus Earnings Call Highlights Profitable Growth Path
TipRanks · 5d ago
More
About EOLS
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.